PKP2 gene therapy reduces ventricular arrhythmias, reverses ventricular remodeling, improves heart function, and reduces mortality in a mouse model of arrhythmogenic right ventricular cardiomyopathy
Zhihong Yang(Indiana University – Purdue University Indianapolis), Cristina Dee-Hoskins, I‐Chien Wu, Farshad Farshidfar(Institute for Stem Cell Biology and Regenerative Medicine), A Zeng, J. Alex Aycinena, Anley E. Tefera, Brian Lim, Christopher M. Reid(The University of Melbourne), Reva Shenwai, Núria Rodríguez, E. Xu, Amara Greer-Short(Unknown), Melissa Van Pell, Tae-Sub Chung
Cited by 1
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
|The Lancet|2022|223
Optimal achieved blood pressure in acute intracerebral hemorrhage
|Neurology|2015|136
A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics
|British Journal of Cancer|2016|136
Revealing the Concealed Nature of Long-QT Type 3 Syndrome
|Circulation Arrhythmia and Electrophysiology|2017|59